BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3319588)

  • 21. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pathogenetic connection between Graves' disease and chronic lymphocytic thyroiditis. (The role and incidence of thyroid stimulating antibodies).
    Leövey A; Bakó G; Sztojka I; Bordán L; Szabó T; Kálmán K; Balázs C
    Acta Med Acad Sci Hung; 1982; 39(1-2):1-6. PubMed ID: 6129766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical management of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM
    Thyroid; 1995 Jun; 5(3):231-4. PubMed ID: 7580273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thyroid-associated ophthalmopathy].
    Kloster R; Elverland HH; Pierre-Jerome C; Trumpy JH
    Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2332-4. PubMed ID: 9691800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of thyroid ophthalmopathies by external orbital radiotherapy].
    Hartemann P; Leclere J; Bey P; Thomas JL; Genton P
    Ann Endocrinol (Paris); 1986; 47(5):389-94. PubMed ID: 3827194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The influence of treatment of progressive edematous infiltrative ophthalmopathy on intraocular pressure].
    Rutecka-Debniak A; Krzystolik Z; Pilarska K; Krzyzanowska-Swiniarska B; Syrenicz A; Jarema A
    Klin Oczna; 1999; 101(3):195-200. PubMed ID: 10526444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endocrine ophthalmopathy].
    Deller M
    Klin Monbl Augenheilkd; 1985 Jun; 186(6):448-9. PubMed ID: 3840216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid eye disease.
    Clifton-Bligh P
    Aust N Z J Ophthalmol; 1990 Aug; 18(3):233-5. PubMed ID: 2261166
    [No Abstract]   [Full Text] [Related]  

  • 30. Results of radiotherapy for thyroid ophthalmopathy.
    Sandler HM; Rubenstein JH; Fowble BL; Sergott RC; Savino PJ; Bosley TM
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):823-7. PubMed ID: 2777672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma exchange in endocrine ophthalmopathy.
    Berlin G; Hjelm H; Liedén G; Tegler L
    J Clin Apher; 1990; 5(4):192-6. PubMed ID: 2228998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid eye disease--medical or surgical therapy?
    Khalid BA; Ng ML
    Ann Acad Med Singap; 1991 Mar; 20(2):273-6. PubMed ID: 1883189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differentiated approach to the treatment of autoimmune ophthalmopathy].
    Mazurov VI; Sviatova LE; Danilichev VF; Cheremisin VM; Gurevich KIa
    Probl Endokrinol (Mosk); 1993; 39(1):24-7. PubMed ID: 8058657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharma-clinics. How I treat ... thyroid ophthalmopathy].
    Joachim M; Andris C; Duchesne B
    Rev Med Liege; 1996 Jul; 51(7):449-52. PubMed ID: 8766533
    [No Abstract]   [Full Text] [Related]  

  • 35. Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy.
    Marcocci C; Marinò M; Rocchi R; Menconi F; Morabito E; Pinchera A
    J Endocrinol Invest; 2004 Mar; 27(3):272-80. PubMed ID: 15165004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The management of Graves' ophthalmopathy.
    Kendall-Taylor P
    Clin Endocrinol (Oxf); 1989 Dec; 31(6):747-56. PubMed ID: 2697480
    [No Abstract]   [Full Text] [Related]  

  • 37. Uniocular fields of fixation in thyroid eye disease.
    Steel DH; Hoh HB; Potts MJ; Harrad RA
    Eye (Lond); 1995; 9 ( Pt 3)():348-51. PubMed ID: 7556746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evidence-based approach to the treatment of Graves' ophthalmopathy.
    Wiersinga WM; Prummel MF
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):297-319, vi-vii. PubMed ID: 10874531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysthyroid ophthalmopathy: an update.
    Young LA
    J Natl Med Assoc; 1979 Sep; 71(9):855-60. PubMed ID: 583054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graves ophthalmopathy.
    Bradley EA
    Curr Opin Ophthalmol; 2001 Oct; 12(5):347-51. PubMed ID: 11588496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.